Explore more publications!
Sci-Tech Today: Africa
Got News to Share?

Sci-Tech Today: Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 10, 2025

Nigeria’s Remittance Inflows Reach USD 23 Billion in 2025, Marking the Highest Level in Five Years
Dec. 10, 2025

Nigeria’s Remittance Inflows Reach USD 23 Billion in 2025, Marking the Highest Level in Five Years

Indeterminate EIN Presswire
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026
Dec. 10, 2025

Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Dec. 10, 2025

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Indeterminate GlobeNewswire
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Dec. 10, 2025

Clearmind Medicine Announces 1-for-40 Reverse Share Split

Indeterminate GlobeNewswire
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
Dec. 10, 2025

Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025
Dec. 10, 2025

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
Dec. 10, 2025

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Indeterminate GlobeNewswire
CommsCloud’s new SIMs make borderless African IoT logistics a reality
Dec. 10, 2025

CommsCloud’s new SIMs make borderless African IoT logistics a reality

Indeterminate EIN Presswire
Observe.AI named a Leader in the IDC MarketScape: AI-Enabled Contact Center Workforce Engagement Management 2025-2026 Vendor Assessment
Dec. 10, 2025

Observe.AI named a Leader in the IDC MarketScape: AI-Enabled Contact Center Workforce Engagement Management 2025-2026 Vendor Assessment

Indeterminate GlobeNewswire
Four Points Technology Awarded a 2025 AWS Partner Award
Dec. 10, 2025

Four Points Technology Awarded a 2025 AWS Partner Award

Indeterminate GlobeNewswire
Photonic Sets New Standard with Distributed Quantum Resource Estimation
Dec. 10, 2025

Photonic Sets New Standard with Distributed Quantum Resource Estimation

Indeterminate GlobeNewswire
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Dec. 10, 2025

Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer

Indeterminate GlobeNewswire
TP in Indonesia Launches TP.ai FAB, Driving the Future of Intelligent, Human-Centered Operations
Dec. 10, 2025

TP in Indonesia Launches TP.ai FAB, Driving the Future of Intelligent, Human-Centered Operations

Indeterminate GlobeNewswire
Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome
Dec. 10, 2025

Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome

Indeterminate GlobeNewswire
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
Dec. 10, 2025

GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique

Indeterminate GlobeNewswire
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  
Dec. 10, 2025

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  

Indeterminate GlobeNewswire
Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI
Dec. 10, 2025

Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions